Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Interest & Investment Income: 2020-2024

Historic Interest & Investment Income for Silence Therapeutics (SLN) over the last 4 years, with Sep 2024 value amounting to $1.3 million.

  • Silence Therapeutics' Interest & Investment Income fell 50.82% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.1 million, marking a year-over-year increase of 404.01%. This contributed to the annual value of $1.8 million for FY2023, which is 14.25% up from last year.
  • According to the latest figures from Q3 2024, Silence Therapeutics' Interest & Investment Income is $1.3 million, which was down 5.18% from $1.3 million recorded in Q2 2024.
  • In the past 5 years, Silence Therapeutics' Interest & Investment Income registered a high of $189.7 million during Q3 2020, and its lowest value of -$1.3 billion during Q4 2020.
  • Moreover, its 3-year median value for Interest & Investment Income was $842,481 (2022), whereas its average is $749,070.
  • Examining YoY changes over the last 5 years, Silence Therapeutics' Interest & Investment Income showed a top increase of 1,150.29% in 2022 and a maximum decrease of 177,430.04% in 2022.
  • Over the past 5 years, Silence Therapeutics' Interest & Investment Income (Quarterly) stood at -$1.3 billion in 2020, then skyrocketed by 100.00% to $2,696 in 2021, then tumbled by 177,430.04% to -$4.8 million in 2022, then spiked by 110.07% to $481,567 in 2023, then tumbled by 50.82% to $1.3 million in 2024.
  • Its Interest & Investment Income stands at $1.3 million for Q3 2024, versus $1.3 million for Q2 2024 and $1.0 million for Q1 2024.